Objective: Nonsyndromic cleft lip with or without cleft palate (NSCL6P) is a common craniofacial anomaly of complex etiology in people. WNT pathway genes have important roles during craniofacial development, and an association of WNT genes with NSCL6P has been demonstrated in different populations. The aim of this study was to evaluate the association between polymorphisms in WNT3 and WNT9B genes and CL/P in Brazilian families.
Human development is a complex event that requires the integration of various mechanisms to allow proper formation of all structures. Cleft lip with or without cleft palate, one of the most common craniofacial anomalies in humans, may occur as part of a syndrome or may be isolated, wherein the affected persons do not present any associated structural anomalies. More than 300 syndromes, including some that are chromosomal or Mendelian, may present a cleft of the lip and/or the palate as a feature, and these make up about 30% of all cleft cases. The remaining 70% are attributed to isolated, nonsyndromic oral clefts without any associated structural anomaly (Gorlin et al., 2001) . Nonsyndromic cleft lip with or without cleft palate (NSCL6P) has a prevalence of 1 or 2 per 1000 live births, depending on the population, and the etiology includes genetic and environmental factors acting individually or interactively (Murray, 2002) .
The wingless-type MMTV integration site family (Wnt) signaling pathway plays an important role in craniofacial development. Wnt signaling genes are conserved among species and are essential to the development of several processes, including face morphogenesis (Fossat et al., 2011) . Studies using animal models have revealed that these genes are expressed in the midface of mice and chickens (Lan et al., 2006; Brugmann et al., 2007; Song et al., 2009; Reid et al., 2011) and that Wnt signaling plays an important role in various aspects of craniofacial development in many species. Loss of function of WNT genes is associated with defects in the facial region, incomplete penetrance of cleft lip, and defects in kidney morphogenesis in homozygous mice mutants (Carroll et al., 2005) . Variations in Wnt5a that cause the loss of expression have been associated with complete clefting of the secondary palate and altered expression of several genes, including sonic hedgehog (Shh), bone morphogenetic protein 4 (Bmp4), msh homeobox 1 (Msx1), and patched 1 (Ptch1), in the palate of Wnt5 knockout mice (He et al., 2008) . Further, Wnt3 and Wnt9b genes are located on chromosome 11 within the clf1 locus, which is associated with the spontaneous development of cleft lip and/or cleft palate (CL/P) in A/WySn mouse strains (Juriloff et al., 2005 (Juriloff et al., , 2006 . Interestingly, this region is syntenic to the human chromosome 17q21, which is known to be associated with NSCL6P in humans (Carinci et al., 2007) .
Studies in humans also point toward a likely role of Wnt pathway genes in the etiology of craniofacial defects in humans. A study of a consanguineous family with tetraamelia, a disorder characterized by complete limb agenesis and other anomalies, including cleft lip with or without cleft palate, has been associated with a nonsense mutation (Q83X) in the WNT3 gene (Niemann et al., 2004) . In addition, polymorphic variants in WNT3, WNT3A, WNT5A, WNT9B, and WNT11 genes have been associated with NSCL6P in different populations (Chiquet et al., 2008; Nikopensius et al., 2011; Yao et al., 2011; Mostowska et al., 2012) , including a case-control study in a Brazilian population (Menezes et al., 2010) . The aim of this study was to evaluate the association between polymorphisms in WNT3 and WNT9B genes and NSCL6P in Brazilian families with NSCL6P.
MATERIALS AND METHODS

Subjects
Seventy nuclear families, each consisting of a child with cleft lip/palate (probands) and unaffected parents (210 persons), were recruited for this study at Hospital Nossa Senhora do Loreto (Rio de Janeiro, Brazil). Only persons with NSCL6P were recruited for the study, as determined by patient records. The average age of persons with NSCL6P was 3.1 6 2.8 years (range ¼ 2 months to 13 years). The average maternal age was 23.4 6 13.2 years (range ¼ 13 years to 40 years) and the average paternal age was 25 6 17 (range ¼ 18 years to 56 years). Written informed consent to participate in the study was obtained from all probands and their parents or legal guardians. This study was approved by the Human Ethics Committee of the Health Department of the City of Rio de Janeiro, Rio de Janeiro, Brazil (Process #113/09).
Genotyping
Saliva samples were collected as the source of genomic DNA using Oragene saliva collection kits (DNA Genotek, Ontario, CA). DNA extraction followed using the manufacturer's recommendations.
We selected three single nucleotide polymorphisms (SNPs) in WNT3 and two in WNT9B (Table 1) to be genotyped, based on previously published findings for association with NSCL6P in humans (Chiquet et al., 2008; Menezes et al., 2010) or their location within the genes. Genotyping was performed using 5 ng/lL DNA in a 10-lL final reaction volume using TaqMan chemistry (Ranade et al., 2001) and detected on a ViiA7 Sequence Detection System (Applied Bio-systems, Foster City, CA). Genotyping was performed blinded to sample status.
Statistical Analyses
Power calculations were performed using the Genetic Power Calculator and indicated that the sample size would provide approximately 98% statistical power to detect an association with an alpha of 0.05, if the markers selected were in linkage disequilibrium with the causal factor (D' ¼ 0.8) and their frequencies were around 20% (Purcell et al., 2003) (data not shown).
The transmission disequilibrium test was used to examine the transmission of alleles from heterozygous parents to affected offspring, as implemented in the Family Based Association Test (FBAT) software (http://biosun1.harvard.edu/ifbat/fbat.htm) (Horvath et al., 2001) . The FBAT uses a score test statistic to compare expected genotypes among offspring under the assumption of no association between observed genotype counts and the phenotype Rabinowitz and Laird, 2000) . The level of significance was established at P .01 after Bonferroni correction considering the number of tests (five) performed. Haplotype analyses were performed to test for linkage between WNT3 and WNT9B loci and NSCL6P using the haplotype-based association test function implemented in FBAT.
In Silico Analyses
We searched for potential transcription factor binding sites in the sequence of the associated SNP rs1530364 using FastSnp (http://fastsnp.ibms.sinica.edu.tw) and SNPinfo (http://snpinfo.niehs.nih.gov/cgi-bin/snpinfo/ snpfunc.cgi).
RESULTS
We found strong evidence of genotypic and allelic association for a SNP (rs1530364) in WNT9B with NSCL6P (P ¼ .001). This polymorphism is located in an intronic region at position 42306776. In silico analyses of SNP function did not reveal any potential interactions that would affect WNT9B gene regulation.
No association was found for SNPs in WNT3 and NSCL6P in our population ( Table 2 ). Haplotype analysis of polymorphisms in the WNT3 and WNT9B genes revealed SNP combinations associated with a risk for NSCL6P. Namely, a haplotype comprising WNT3 rs199525-T, rs111769-C, and rs3851781-C and WNT9B rs1260243-C and rs1530364-G was also associated with NSCL6P (global P value ¼ .012) ( Table 3) .
DISCUSSION
Wnt signaling molecules constitute a family of conserved secreted glycoproteins that play fundamental roles in developmental and biological processes (Wodarz et al., 1998) . The WNT genes are involved in regulating midface development and upper lip fusion and are therefore candidates for an etiologic role in NSCL6P. Evidence supporting WNT genes as possible clefting loci come from studies with the inbred A/WySn mouse strain, in which Wnt3 and Wnt9B genes are located in the clf1 region and contribute to a clefting phenotype (Juriloff et al., 2004; Juriloff et al., 2005) . In humans, variations in WNT genes have been described in patients with syndromic (Niemann et al., 2004) and nonsyndromic CL/P (Chiquet et al., 2008; Menezes et al., 2010; Nikopensius et al. 2011; Yao et al., 2011; Mostowska et al., 2012) .
In this study, we investigated SNPs in WNT3 and WNT9B as possible candidates in the etiology of NSCL6P in Brazilian families. The families in the present study consisted of 70 parent-patient trios from the southeastern region of Brazil, which constitute mostly persons of European descent. Although the small sample size is a limitation of the study, and the results may not extrapolate to the general population, power calculations indicated that the sample size would provide approximately 98% statistical power to detect an association. Our results showed a strong association of an intronic SNP (rs1530364) in WNT9B with NSCL6P; however, no association was found for SNPs in WNT3.
The association of WNT9B with NSCL6P has also been shown in previous family-based studies with NSCL6P families and cases and controls of European ancestry (Chiquet et al., 2008; Menezes et al., 2010; Nikopensius et al., 2011) . Further, and similar to these studies where haplotypes including markers in WNT9B showed strong association with NSCL6P, we also observed significant association of haplotypes, including markers in WNT9B and WNT3 with NSCL6P in the families in this study. Evidence for an epistatic interaction was also identified between SNPs in WNT9B and MSX1, another established cleft susceptibility gene (Nikopensius et al., 2011) .
The WNT9B lies approximately 32 kb telomeric from the start codon of WNT3, which is required at the earliest stages of human limb formation and for craniofacial morphogenesis. In our study, the associated intronic SNP (rs1530364) in WNT9B does not appear to alter transcription factor-binding sites or to have potential detrimental effects because of the fact that introns are transcribed into the pre-mRNA but removed during formation of mature mRNA and therefore not translated into the peptide. Nevertheless, although the associated SNP may not have a direct effect on the etiology of NSCL6P, it may be in linkage disequilibrium with a true causal variant, within WNT9B or in other potential candidate genes. NSCL6P is a complex disorder and may exhibit different associated clinical subphenotypes (Weinberg et al., 2006) . The use of a broadened phenotype description, including information on the cleft type and side, presence of lip whorls, dental anomalies, and discontinuity of the oral orbicularis muscle in persons with NSCL6P, has been suggested to increase the likelihood of finding a causative gene in association with the condition (Weinberg et al., 2006; Letra et al., 2007; Marazita et al., 2007; Neiswanger et al., 2009) . Moreover, these cleft subphenotypes could be used to verify whether a particular gene is preferentially associated with a certain subphenotype (Letra et al., 2007) . In this context, the preferential association of a SNP in WNT5A (rs566926) with cases of unilateral left-sided NSCL6P has been described, although no association was detected for the overall NSCL6P group (Menezes et al., 2010) . This suggests that specific genes may contribute differently to each NSCL6P phenotype. In this study, we only performed analysis for a combined NSCL6P group, as stratifying our analysis by different CL/P subgroups (unilateral, bilateral, left, or right) would decrease statistic power because of the reduced sample size. This may explain any discrepancies between our results and those of previous reports (Menezes et al., 2010) . Nevertheless, a combined NSCL6P group, as used in this study, is still the most widely used approach in genetic studies of NSCL6P (Grant et al., 2009; Birnbaum et al., 2010; Letra et al., 2012; Beaty et al., 2013) .
In summary, a number of observations suggest that WNT genes, particularly WNT9B and WNT3, may be involved in the etiology of NSCL6P (Chiquet et al., 2008; Menezes et al., 2010; Yao et al., 2011; Mostowska et al., 2012) . Although in this study no associations were found for WNT3 and NSCL6P, our study further supports the involvement of WNT9B as a cleft susceptibility gene in Brazilian families in which NSCL6P appears. Although additional studies are still necessary to unveil the exact mechanism by which WNT genes would contribute to NSCL6P, allelic polymorphisms in these genes and their interactions may partly explain the variance of individual susceptibility to NSCL6P. 
